At a summit on Thursday, EU departments were vacated over vaccine distribution because the government failed to agree on how it could provide additional jobs to member countries in need of emergency supplies.
The leaders clashed during a marathon video conference that ended without a decision on the demand for an additional 10 million bioentech / Pfizer vaccines, mainly from poor former member states.
Tensions and occasional rogue talks erupted after Austrian Chancellor Sebastian Kurz’s demand for additional vaccines in Vienna was rejected by leaders, including German Chancellor Angela Merkel.
Kurz was part of a group of EU countries that were given extra doses after being affected by Austria in an effort to ensure that Estrogen supply deficit. But his demands for the transfer of most jobs in Austria, the Czech Republic and Croatia were rejected by leaders who questioned Vienna’s need for more risky countries in Eastern Europe, following the rest.
Dutch Prime Minister Mark Rutte said the rollout of the vaccine in Austria was “not in a bad position” and that the bloc should be considered a priority in Bulgaria, Croatia and Latvia. The three countries have regularly outperformed the average EU vaccination rate after weighing their purchases towards asylum-seeking AstraZeneca jabs due to supply delays.
EU officials spent last week at Loggerhead discussing how to deliver a portion of the 10-meter Pfizer job delivery it brought to the front of the third quarter.
After Kurz Vienna did so, the hopes of an agreement were settled Veto no distribution agreement It did not include the extended portion for Austria.
Merkel was frustrated by Austrian criticism of EU rules, and people briefed on the issue. He told the summit that vaccine agreements were “signed by member countries and not by some stupid bureaucrats”.
Although all EU countries are entitled to a share-population-based share of each vaccine purchased by the European Commission, they may accept less of each job if they wish. Any unused shares can then be purchased by other member states.
Leaders have debated tougher export sanctions and heard the address, underestimating the growing divisions within the EU over the vaccine rollout. US President Joe Biden. Many European Union countries are battling new cases of the virus, with Belgium and France forced to re-lock this week.
The commission this week proposed that the European Union tighten prudent export controls as it pressures beneficiary countries, particularly the UK, to share their own production.
The European Union has exported 77 million vaccines to more than 40 middle-income countries since December 1, according to commission figures released on Thursday – distributed in about 7 million blocks. About 21 million doses have been shipped to the UK, EU officials said, including about 1 meter of AstraZeneca jabs sent before the EU export system took effect in late January.
After the summit, French President Emmanuel Macron said: “Europe is not a selfish continent. When I read the British press we hear that the EU is selfish. That’s a lie. “
According to data collected by the Financial Times, 1-meter astrageneca doses could not materially close the gap between EU and UK inoculation drives, which vaccinated 3.4 times more people per capita. But the British shipment sparked a controversy between London and the EU capitals, which was angered by the lack of exports from Europe.
Discussions continue between London and Brussels over Britain’s claim that millions of AstraZeneca doses are available at a plant in the Netherlands.
Matt Hancock, The UK’s health secretary, argued this week that the British government took the priority because the EU had the “best effort” agreement and we have an exclusivity agreement ”.
EU officials, however, noted that the British agreement with AstraZeneca uses the same “best reasonable effort” language to define the company’s supply responsibilities.
They further said that AstraZeneca should have sent EU production from the UK factory, which is mentioned in the agreement with the commission’s supply agency.